Chrome Extension
WeChat Mini Program
Use on ChatGLM

Prospective, Multicenter Validation of a Platform for Rapid Molecular Profiling of Central Nervous System Tumors

Areeba Patel, Kirsten GöbelMartin Sill,Felix Sahm

Nature Medicine(2025)SCI 1区

Department of Neuropathology | Department of Neurosurgery | German Cancer Research Center (DKFZ) | Goethe University | Institute for Pathology | Center for Medical Genetics Ghent | Department of Pathology | Vilhelm Magnus Laboratory | School of Life Sciences | School of Medicine | University College London Hospitals NHS Foundation Trust | Cincinnati Children's Hospital Medical Center | Brain Tumor Translational Targets | Hopp Children's Tumor Center (KiTZ) | Department of Neurology | Biomedical Informatics | University Hospital Heidelberg

Cited 0|Views4
Abstract
Molecular data integration plays a central role in central nervous system (CNS) tumor diagnostics but currently used assays pose limitations due to technical complexity, equipment and reagent costs, as well as lengthy turnaround times. We previously reported the development of Rapid-CNS2, an adaptive-sampling-based nanopore sequencing workflow. Here we comprehensively validated and further developed Rapid-CNS2 for intraoperative use. It now offers real-time methylation classification and DNA copy number information within a 30-min intraoperative window, followed by comprehensive molecular profiling within 24 h, covering the complete spectrum of diagnostically and therapeutically relevant information for the respective entity. We validated Rapid-CNS2 in a multicenter setting on 301 archival and prospective samples including 18 samples sequenced intraoperatively. To broaden the utility of methylation-based CNS tumor classification, we developed MNP-Flex, a platform-agnostic methylation classifier encompassing 184 classes. MNP-Flex achieved 99.6% accuracy for methylation families and 99.2% accuracy for methylation classes with clinically applicable thresholds across a global validation cohort of more than 78,000 frozen and formalin-fixed paraffin-embedded samples spanning five different technologies. Integration of these tools has the potential to advance CNS tumor diagnostics by providing broad access to rapid, actionable molecular insights crucial for personalized treatment strategies.
More
Translated text
PDF
Bibtex
AI Read Science
AI Summary
AI Summary is the key point extracted automatically understanding the full text of the paper, including the background, methods, results, conclusions, icons and other key content, so that you can get the outline of the paper at a glance.
Example
Background
Key content
Introduction
Methods
Results
Related work
Fund
Key content
  • Pretraining has recently greatly promoted the development of natural language processing (NLP)
  • We show that M6 outperforms the baselines in multimodal downstream tasks, and the large M6 with 10 parameters can reach a better performance
  • We propose a method called M6 that is able to process information of multiple modalities and perform both single-modal and cross-modal understanding and generation
  • The model is scaled to large model with 10 billion parameters with sophisticated deployment, and the 10 -parameter M6-large is the largest pretrained model in Chinese
  • Experimental results show that our proposed M6 outperforms the baseline in a number of downstream tasks concerning both single modality and multiple modalities We will continue the pretraining of extremely large models by increasing data to explore the limit of its performance
Try using models to generate summary,it takes about 60s
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn
Chat Paper

要点】:本研究在多中心环境中验证并进一步开发了Rapid-CNS2平台,实现实时中枢神经系统肿瘤分子分类及DNA拷贝数分析,以提供个性化治疗策略所需的快速、可操作的分子信息。

方法】:研究采用自适应采样技术的纳米孔测序工作流程Rapid-CNS2,结合MNP-Flex通用甲基化分类器,对中枢神经系统肿瘤样本进行快速分子分析。

实验】:研究者在多中心设置中对301个存档和前瞻性样本进行了验证,包括18个术中测序样本,MNP-Flex在超过78,000个冷冻和福尔马林固定石蜡包埋样本中,跨五种技术平台达到了99.6%的甲基化家族准确度和99.2%的甲基化分类准确度。